# Virchow Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virchow-medical

- Industry: Medical Devices & Equipment
- Headquarters: La Jolla, US
- Website: www.virchowmed.com
- Total disclosed funding: $4M
- Latest round: Seed (Mar 24, 2026)
- Investors on record: 1

## About

Virchow Medical, Inc., based in the US, specializes in advanced biopsy solutions, focusing on enhancing cancer diagnostics through innovative technologies and precision medicine.Virchow Medical, Inc. was founded in 2023 and is headquartered in La Jolla, US. The company provides advanced biopsy solutions aimed at improving cancer diagnostics. In March 2026, Virchow Medical raised USD 4.00 mn in Seed funding led by Cerberus Capital Management, with the total amount raised to USD 4.00 mn. The company has participated in one deal to date.Virchow Medical, Inc. specializes in advanced biopsy solutions, primarily through its flagship product, the Virchow Vault. This product is designed to enhance tumor cell utilization efficiency, allowing healthcare providers to gain multiple diagnostic insights from a single biopsy sample. By leveraging innovative techniques in liquid companion specimens, the company addresses critical needs for improved cancer diagnostics and monitoring. Its offerings serve medical professionals, including oncologists and interventional radiologists, across North America and Europe, positioning the Virchow Vault as a transformative tool in precision medicine.Virchow Medical, Inc. generates revenue through a direct-to-consumer model, offering specialized biopsy solutions to healthcare facilities and professionals. Providers typically purchase the Virchow Vault and associated services as part of their diagnostic offerings, leading to revenue through one-time product sales and potential subscription services for ongoing support and updates. The company focuses on developing long-term relationships with clients in oncology to ensure timely and accurate diagnostics, aligning its revenue streams with the growing demand for precision medicine solutions.In March 2026, Virchow Medical, Inc. raised USD 4.00 mn in Seed funding, which will be utilized to support product development, increase production, and expand its sample storage and testing operations. The company aims to launch new products that enhance biopsy solutions, although specific release dates have yet to be announced. Additionally, Virchow Medical plans to expand into new markets in Europe and Asia by 2027, further broadening its reach in the oncology sector.

## Funding rounds

- Seed, Mar 24, 2026, $4M — Cerberus Capital Management

## Investors

- Cerberus Capital Management (https://capitalatlas.ai/funds/cerberus-capital-management) — Seed